Wai Conrad's Form 4 filing
Clover Health Investments, Corp. (CLOV) · filed Sep 16, 2026
- Accession no.
- 0001971702-26-000017
- Filed
- Sep 16, 2026, 4:27 PM ET
- Trade date
- Sep 15, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $1.42M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wai ConradCIK 0001971702 | Officer (CEO, Counterpart Health) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Class A Common Stock | SSaleDisposed | −300,000 | $4.72 | −$1,416,000 | 1,170,056 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.